Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADA 2019
Pharma
ADA '19 goes beyond diabetes as 'holistic' care comes into focus
If you'd popped into ADA, you might have thought you’d wandered into a kidney disease or NASH meeting. And that has drugmakers excited.
Carly Helfand
Jun 12, 2019 12:04pm
Novo Nordisk's oral semaglutide posts another heart safety win
Jun 11, 2019 8:14pm
J&J's Invokana slashes heart, kidney risks in latest trial win
Jun 11, 2019 12:06pm
Lilly, BI's Tradjenta ties generic rival in heart safety study
Jun 11, 2019 11:18am
Sanofi's Toujeo tops Tresiba in tough-to-treat diabetes group
Jun 10, 2019 11:05am
AstraZeneca's Farxiga scores in kidney outcomes study
Jun 10, 2019 3:27am
